Medical Properties (MPW) stock soared today after the real estate investment trust (REIT) released its Q4 2024 earnings report. The good news starts with adjusted earnings per share of 18 cents easily beating Wall Street’s estimate of -6 cents. It’s also a massive improvement over the -$1.11 reported in Q4 2023.
Revenue reported by Medical Properties came in at 231.84 million, securing another win for MPW stockholders compared to analysts’ estimate of $216.87 million. Investors will also note it’s a positive change from the company’s loss of $122.38 million in the same period of 2023.
Investor excitement is high after these strong results, pushing shares of MPW stock 6.5% higher today. That builds on a 28.61% rally year-to-date and a 34.04% increase over the past 52 weeks.
What’s Next for MPW Stock?
Medical Properties Chairman, President, and CEO Edward Aldag, Jr. is optimistic about the company’s future after its latest earnings report. He points to its accelerated “repayment of debt maturities” and a “five-and-a-half times oversubscribed secured notes transaction” as highlights of the year.
The Medical Properties CEO also points out that the REIT’s “global real estate portfolio remains attractive” while “all debt maturities through 2026” have been addressed. This positions the company to “pursue a range of shareholder value initiatives in 2025.”
Is MPW Stock a Buy, Sell, or Hold?
Turning to Wall Street, the analysts’ consensus rating for Medical Properties is Moderate Sell based on three Hold and two Sell ratings over the last three months. With that comes an average price target of $4.33, a high of $5, and a low of $4. This represents a potential 15.26% downside for MPW stock. These ratings and price targets will likely change as analysts update their coverage after today’s earnings report.
